Empowering Diversity in Clinical Trials.
Empowering Diversity in Clinical Trials.
Diverse audiences want to participate in clinical trials but so often, are not asked, overlooked, or unable to access because of income, education, geographical location, and discrimination based on ethnicity, race, gender, sexual orientation, age, disability, and lifestyle.
Diverse audiences want to participate in clinical trials but so often, are not asked, overlooked, or unable to access because of income, education, geographical location, and discrimination based on ethnicity, race, gender, sexual orientation, age, disability, and lifestyle.
We make clinical research more accessible to underserved populations to enable faster enrollment, better retention and more representative of real-world populations.
Diverse audiences want to participate in clinical trials but so often, are not asked, overlooked, or unable to access because of income, education, geographical location, and discrimination based on ethnicity, race, gender, sexual orientation, age, disability, and lifestyle.
The Science 37 Metasite™ expands reach with a flexible model that improves equity and access. Discover how Science 37 delivers faster enrollment, greater retention, and a more representative patient population.
We make clinical research more accessible to underserved populations to enable faster enrollment, better retention and more representative of real-world populations.
Diverse audiences want to participate in clinical trials but so often, are not asked, overlooked, or unable to access because of income, education, geographical location, and discrimination based on ethnicity, race, gender, sexual orientation, age, disability, and lifestyle.
The Science 37 Metasite™ expands reach with a flexible model that improves equity and access. Discover how Science 37 delivers faster enrollment, greater retention, and a more representative patient population.
Resources
Resources
Are you ready for the DEPICT Act?
The Diverse and Equitable Participation in Clinical Trials (DEPICT) Act is a proposed new US legislation aimed at boosting diversity in clinical trials. Once passed, new diversity enrollment targets will be introduced for Investigational New Drug applicants.
To learn more about the DEPICT Act and how we can help you reach your diversity targets, speak to one of our experts today.
Are you ready for the DEPICT Act?
The Diverse and Equitable Participation in Clinical Trials (DEPICT) Act is a proposed new US legislation aimed at boosting diversity in clinical trials. Once passed, new diversity enrollment targets will be introduced for Investigational New Drug applicants.
To learn more about the DEPICT Act and how we can help you reach your diversity targets, speak to one of our experts today.